{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:25:01Z","timestamp":1790857501672,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010905","name":"Major Research Plan","doi-asserted-by":"publisher","award":["81670389"],"award-info":[{"award-number":["81670389"]}],"id":[{"id":"10.13039\/501100010905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic kidney disease (CKD) accelerates atherosclerosis, but the mechanisms remain unclear. Tyrosine sulfation has been recognized as a key post-translational modification (PTM) in regulation of various cellular processes, and the sulfated adhesion molecules and chemokine receptors have been shown to participate in the pathogenesis of atherosclerosis via enhancement of monocyte\/macrophage function. The levels of inorganic sulfate, the essential substrate for the sulfation reaction, are dramatically increased in patients with CKD, which indicates a change of sulfation status in CKD patients. Thus, in the present study, we detected the sulfation status in CKD patients and probed into the impact of sulfation on CKD-related atherosclerosis by targeting tyrosine sulfation function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PBMCs from individuals with CKD showed higher amounts of total sulfotyrosine and tyrosylprotein sulfotransferase (TPST) type 1 and 2 protein levels. The plasma level of O-sulfotyrosine, the metabolic end product of tyrosine sulfation, increased significantly in CKD patients. Statistically, O-sulfotyrosine and the coronary atherosclerosis severity SYNTAX score positively correlated. Mechanically, more sulfate-positive nucleated cells in peripheral blood and more abundant infiltration of sulfated macrophages in deteriorated vascular plaques in CKD ApoE null mice were noted. Knockout of TPST1 and TPST2 decreased atherosclerosis and peritoneal macrophage adherence and migration in CKD condition. The sulfation of the chemokine receptors, CCR2 and CCR5, was increased in PBMCs from CKD patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>CKD is associated with increased sulfation status. Increased sulfation contributes to monocyte\/macrophage activation and might be involved in CKD-related atherosclerosis. Inhibition of sulfation may suppress CKD-related atherosclerosis and is worthy of further study.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12915-023-01641-y","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:01:41Z","timestamp":1688947301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Daopeng","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2053-0135","authenticated-orcid":false,"given":"Jinzhou","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"1641_CR1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296\u2013305.","journal-title":"N Engl J Med"},{"key":"1641_CR2","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1097\/01.ASN.0000128365.76153.5B","volume":"15","author":"K Amann","year":"2004","unstructured":"Amann K, Gross ML, Ritz E. Pathophysiology underlying accelerated atherogenesis in renal disease: closing in on the target. J Am Soc Nephrol. 2004;15:1664\u20136.","journal-title":"J Am Soc Nephrol"},{"key":"1641_CR3","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1681\/ASN.2016050562","volume":"28","author":"B Thomas","year":"2017","unstructured":"Thomas B, Matsushita K, Abate KH, Al-Aly Z, Arnlov J, Asayama K, Atkins R, Badawi A, Ballew SH, Banerjee A, Barregard L, Barrett-Connor E, Basu S, Bello AK, Bensenor I, Bergstrom J, Bikbov B, Blosser C, Brenner H, Carrero JJ, Chadban S, Cirillo M, Cortinovis M, Courville K, Dandona L, Dandona R, Estep K, Fernandes J, Fischer F, Fox C, Gansevoort RT, Gona PN, Gutierrez OM, Hamidi S, Hanson SW, Himmelfarb J, Jassal SK, Jee SH, Jha V, Jimenez-Corona A, Jonas JB, Kengne AP, Khader Y, Khang YH, Kim YJ, Klein B, Klein R, Kokubo Y, Kolte D, Lee K, Levey AS, Li Y, Lotufo P, El Razek HMA, Mendoza W, Metoki H, Mok Y, Muraki I, Muntner PM, Noda H, Ohkubo T, Ortiz A, Perico N, Polkinghorne K, Al-Radaddi R, Remuzzi G, Roth G, Rothenbacher D, Satoh M, Saum KU, Sawhney M, Schottker B, Shankar A, Shlipak M, Silva DAS, Toyoshima H, Ukwaja K, Umesawa M, Vollset SE, Warnock DG, Werdecker A, Yamagishi K, Yano Y, Yonemoto N, Zaki MES, Naghavi M, Forouzanfar MH, Murray CJL, Coresh J, Vos T, Global Burden of Disease GFRC, Consortium CKDP, Global Burden of Disease Genitourinary Expert G. Global Cardiovascular and Renal Outcomes of Reduced GFR. J Am Soc Nephrol. 2017;28:2167\u201379.","journal-title":"J Am Soc Nephrol"},{"key":"1641_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.ajkd.2006.05.021","volume":"48","author":"DE Weiner","year":"2006","unstructured":"Weiner DE, Tabatabai S, Tighiouart H, Elsayed E, Bansal N, Griffith J, Salem DN, Levey AS, Sarnak MJ. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis. 2006;48:392\u2013401.","journal-title":"Am J Kidney Dis"},{"key":"1641_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","volume":"50","author":"DE Weiner","year":"2007","unstructured":"Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, Sarnak MJ. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50:217\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"1641_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/1440-1681.13018","volume":"45","author":"Y Ishimoto","year":"2018","unstructured":"Ishimoto Y, Tanaka T, Yoshida Y, Inagi R. Physiological and pathophysiological role of reactive oxygen species and reactive nitrogen species in the kidney. Clin Exp Pharmacol Physiol. 2018;45:1097\u2013105.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1641_CR7","doi-asserted-by":"crossref","unstructured":"Kaur J, Young BE, Fadel PJ. Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms. Int J Mol Sci. 2017;18:1682.","DOI":"10.3390\/ijms18081682"},{"key":"1641_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.02.047","volume":"53","author":"FG Hage","year":"2009","unstructured":"Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, DeMattos AM, Iskandrian AE. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol. 2009;53:2129\u201340.","journal-title":"J Am Coll Cardiol"},{"key":"1641_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ki.2015.287","volume":"89","author":"YJ Jing","year":"2016","unstructured":"Jing YJ, Ni JW, Ding FH, Fang YH, Wang XQ, Wang HB, Chen XN, Chen N, Zhan WW, Lu L, Zhang RY. p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE-\/- mice. Kidney Int. 2016;89:439\u201349.","journal-title":"Kidney Int"},{"key":"1641_CR10","doi-asserted-by":"crossref","unstructured":"Corbeil D, Thiele C, Huttner WB. Tyrosine O-sulfation. Curr Protoc Protein Sci. 2005;Chapter 14:14.7.1\u201314.","DOI":"10.1002\/0471140864.ps1407s39"},{"key":"1641_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/299273a0","volume":"299","author":"WB Huttner","year":"1982","unstructured":"Huttner WB. Sulphation of tyrosine residues-a widespread modification of proteins. Nature. 1982;299:273\u20136.","journal-title":"Nature"},{"key":"1641_CR12","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.2174\/138920101314151120122922","volume":"13","author":"N Sasaki","year":"2012","unstructured":"Sasaki N. Current status and future prospects for research on tyrosine sulfation. Curr Pharm Biotechnol. 2012;13:2632\u201341.","journal-title":"Curr Pharm Biotechnol"},{"key":"1641_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.autrev.2005.03.004","volume":"4","author":"W Hsu","year":"2005","unstructured":"Hsu W, Rosenquist GL, Ansari AA, Gershwin ME. Autoimmunity and tyrosine sulfation. Autoimmun Rev. 2005;4:429\u201335.","journal-title":"Autoimmun Rev"},{"key":"1641_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0092-8674(95)90174-4","volume":"83","author":"T Pouyani","year":"1995","unstructured":"Pouyani T, Seed B. PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell. 1995;83:333\u201343.","journal-title":"Cell"},{"key":"1641_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0092-8674(03)00508-7","volume":"114","author":"H Choe","year":"2003","unstructured":"Choe H, Li W, Wright PL, Vasilieva N, Venturi M, Huang CC, Grundner C, Dorfman T, Zwick MB, Wang L, Rosenberg ES, Kwong PD, Burton DR, Robinson JE, Sodroski JG, Farzan M. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell. 2003;114:161\u201370.","journal-title":"Cell"},{"key":"1641_CR16","doi-asserted-by":"crossref","unstructured":"Moussouras NA, Getschman AE, Lackner ER, Veldkamp CT, Dwinell MB, Volkman BF. Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands. Int J Mol Sci. 2017;18:1894.","DOI":"10.3390\/ijms18091894"},{"key":"1641_CR17","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1021\/acs.accounts.5b00255","volume":"48","author":"MJ Stone","year":"2015","unstructured":"Stone MJ, Payne RJ. Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function. Acc Chem Res. 2015;48:2251\u201361.","journal-title":"Acc Chem Res"},{"key":"1641_CR18","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1161\/ATVBAHA.109.195552","volume":"29","author":"E Koltsova","year":"2009","unstructured":"Koltsova E, Ley K. Tyrosine sulfation of leukocyte adhesion molecules and chemokine receptors promotes atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1709\u201311.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1641_CR19","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1161\/ATVBAHA.109.192963","volume":"29","author":"AD Westmuckett","year":"2009","unstructured":"Westmuckett AD, Moore KL. Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-\/- mice. Arterioscler Thromb Vasc Biol. 2009;29:1730\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1641_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/ki.1979.22","volume":"15","author":"RM Freeman","year":"1979","unstructured":"Freeman RM, Richards CJ. Studies on sulfate in end-stage renal disease. Kidney Int. 1979;15:167\u201375.","journal-title":"Kidney Int"},{"key":"1641_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12882-021-02268-3","volume":"22","author":"S Chen","year":"2021","unstructured":"Chen S, Liu YH, Dai DP, Zhu ZB, Dai Y, Wu ZM, Zhang LP, Duan ZF, Lu L, Ding FH, Zhu JZ, Zhang RY. Using circulating O-sulfotyrosine in the differential diagnosis of acute kidney injury and chronic kidney disease. BMC Nephrol. 2021;22:66.","journal-title":"BMC Nephrol"},{"key":"1641_CR22","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1097\/01.ASN.0000088024.72216.2E","volume":"14","author":"S Bro","year":"2003","unstructured":"Bro S, Bentzon JF, Falk E, Andersen CB, Olgaard K, Nielsen LB. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol. 2003;14:2466\u201374.","journal-title":"J Am Soc Nephrol"},{"key":"1641_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/01.ASN.0000045048.71975.FC","volume":"14","author":"M Buzello","year":"2003","unstructured":"Buzello M, Tornig J, Faulhaber J, Ehmke H, Ritz E, Amann K. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol. 2003;14:311\u20136.","journal-title":"J Am Soc Nephrol"},{"key":"1641_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R. Atherosclerosis\u2013an inflammatory disease. N Engl J Med. 1999;340:115\u201326.","journal-title":"N Engl J Med"},{"key":"1641_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1172\/JCI29950","volume":"117","author":"FK Swirski","year":"2007","unstructured":"Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117:195\u2013205.","journal-title":"J Clin Invest"},{"key":"1641_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/07853890310019961","volume":"36","author":"Y Sheikine","year":"2004","unstructured":"Sheikine Y, Hansson GK. Chemokines and atherosclerosis. Ann Med. 2004;36:98\u2013118.","journal-title":"Ann Med"},{"key":"1641_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0076-6879(06)16023-1","volume":"416","author":"M Sperandio","year":"2006","unstructured":"Sperandio M, Pickard J, Unnikrishnan S, Acton ST, Ley K. Analysis of leukocyte rolling in vivo and in vitro. Methods Enzymol. 2006;416:346\u201371.","journal-title":"Methods Enzymol"},{"key":"1641_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI28549","volume":"117","author":"F Tacke","year":"2007","unstructured":"Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest. 2007;117:185\u201394.","journal-title":"J Clin Invest"},{"key":"1641_CR29","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1083\/jcb.128.4.661","volume":"128","author":"KL Moore","year":"1995","unstructured":"Moore KL, Patel KD, Bruehl RE, Li F, Johnson DA, Lichenstein HS, Cummings RD, Bainton DF, McEver RP. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol. 1995;128:661\u201371.","journal-title":"J Cell Biol"},{"key":"1641_CR30","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1161\/CIRCULATIONAHA.108.771048","volume":"117","author":"G An","year":"2008","unstructured":"An G, Wang H, Tang R, Yago T, McDaniel JM, McGee S, Huo Y, Xia L. P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice. Circulation. 2008;117:3227\u201337.","journal-title":"Circulation"},{"key":"1641_CR31","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1161\/01.CIR.0000065604.56839.18","volume":"107","author":"JW Phillips","year":"2003","unstructured":"Phillips JW, Barringhaus KG, Sanders JM, Hesselbacher SE, Czarnik AC, Manka D, Vestweber D, Ley K, Sarembock IJ. Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation. 2003;107:2244\u20139.","journal-title":"Circulation"},{"key":"1641_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.mie.2019.02.004","volume":"622","author":"J Lawrie","year":"2019","unstructured":"Lawrie J, Niu W, Guo J. Engineering of a sulfotyrosine-recognizing small protein scaffold for the study of protein tyrosine O-sulfation. Methods Enzymol. 2019;622:67\u201389.","journal-title":"Methods Enzymol"},{"key":"1641_CR33","doi-asserted-by":"publisher","first-page":"12053","DOI":"10.1073\/pnas.94.22.12053","volume":"94","author":"WA Kuziel","year":"1997","unstructured":"Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A. 1997;94:12053\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1641_CR34","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/ATVBAHA.113.301655","volume":"34","author":"A Zernecke","year":"2014","unstructured":"Zernecke A, Weber C. Chemokines in atherosclerosis: proceedings resumed. Arterioscler Thromb Vasc Biol. 2014;34:742\u201350.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1641_CR35","doi-asserted-by":"crossref","unstructured":"Bettelheim FR. Tyrosine-O-sulfate in a peptide from fibrinogen. J Am Chem Soc. 1954;10:2838\u20139.","DOI":"10.1021\/ja01639a073"},{"key":"1641_CR36","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/ncomms2593","volume":"4","author":"T Teramoto","year":"2013","unstructured":"Teramoto T, Fujikawa Y, Kawaguchi Y, Kurogi K, Soejima M, Adachi R, Nakanishi Y, Mishiro-Sato E, Liu MC, Sakakibara Y, Suiko M, Kimura M, Kakuta Y. Crystal structure of human tyrosylprotein sulfotransferase-2 reveals the mechanism of protein tyrosine sulfation reaction. Nat Commun. 2013;4:1572.","journal-title":"Nat Commun"},{"key":"1641_CR37","doi-asserted-by":"publisher","first-page":"8776","DOI":"10.1038\/s41598-017-07141-8","volume":"7","author":"S Tanaka","year":"2017","unstructured":"Tanaka S, Nishiyori T, Kojo H, Otsubo R, Tsuruta M, Kurogi K, Liu MC, Suiko M, Sakakibara Y, Kakuta Y. Structural basis for the broad substrate specificity of the human tyrosylprotein sulfotransferase-1. Sci Rep. 2017;7:8776.","journal-title":"Sci Rep"},{"key":"1641_CR38","doi-asserted-by":"publisher","first-page":"23781","DOI":"10.1074\/jbc.M202420200","volume":"277","author":"YB Ouyang","year":"2002","unstructured":"Ouyang YB, Crawley JT, Aston CE, Moore KL. Reduced body weight and increased postimplantation fetal death in tyrosylprotein sulfotransferase-1-deficient mice. J Biol Chem. 2002;277:23781\u20137.","journal-title":"J Biol Chem"},{"key":"1641_CR39","doi-asserted-by":"publisher","first-page":"9423","DOI":"10.1074\/jbc.M513768200","volume":"281","author":"A Borghei","year":"2006","unstructured":"Borghei A, Ouyang YB, Westmuckett AD, Marcello MR, Landel CP, Evans JP, Moore KL. Targeted disruption of tyrosylprotein sulfotransferase-2, an enzyme that catalyzes post-translational protein tyrosine O-sulfation, causes male infertility. J Biol Chem. 2006;281:9423\u201331.","journal-title":"J Biol Chem"},{"key":"1641_CR40","doi-asserted-by":"publisher","first-page":"e71822","DOI":"10.1371\/journal.pone.0071822","volume":"8","author":"AD Westmuckett","year":"2013","unstructured":"Westmuckett AD, Siefert JC, Tesiram YA, Pinson DM, Moore KL. Salivary gland hypofunction in tyrosylprotein sulfotransferase-2 knockout mice is due to primary hypothyroidism. PLoS ONE. 2013;8:e71822.","journal-title":"PLoS ONE"},{"key":"1641_CR41","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.bbrc.2016.12.013","volume":"482","author":"W Zhou","year":"2017","unstructured":"Zhou W, Wang Y, Xie J, Geraghty RJ. A fluorescence-based high-throughput assay to identify inhibitors of tyrosylprotein sulfotransferase activity. Biochem Biophys Res Commun. 2017;482:1207\u201312.","journal-title":"Biochem Biophys Res Commun"},{"key":"1641_CR42","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1042\/BCJ20180266","volume":"475","author":"DP Byrne","year":"2018","unstructured":"Byrne DP, Li Y, Ngamlert P, Ramakrishnan K, Eyers CE, Wells C, Drewry DH, Zuercher WJ, Berry NG, Fernig DG, Eyers PA. New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors. Biochem J. 2018;475:2435\u201355.","journal-title":"Biochem J"},{"key":"1641_CR43","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1042\/BCJ20180480","volume":"475","author":"S Yeoh","year":"2018","unstructured":"Yeoh S, Bayliss R. New tools for evaluating protein tyrosine sulfation and carbohydrate sulfation. Biochem J. 2018;475:3035\u20137.","journal-title":"Biochem J"},{"key":"1641_CR44","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/bioinformatics\/18.5.769","volume":"18","author":"F Monigatti","year":"2002","unstructured":"Monigatti F, Gasteiger E, Bairoch A, Jung E. The Sulfinator: predicting tyrosine sulfation sites in protein sequences. Bioinformatics. 2002;18:769\u201370.","journal-title":"Bioinformatics"},{"key":"1641_CR45","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1021\/acs.jcim.7b00688","volume":"58","author":"M Cao","year":"2018","unstructured":"Cao M, Chen G, Wang L, Wen P, Shi S. Computational Prediction and Analysis for Tyrosine Post-Translational Modifications via Elastic Net. J Chem Inf Model. 2018;58:1272\u201381.","journal-title":"J Chem Inf Model"},{"key":"1641_CR46","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1038\/s41467-020-18629-9","volume":"11","author":"X He","year":"2020","unstructured":"He X, Chen Y, Beltran DG, Kelly M, Ma B, Lawrie J, Wang F, Dodds E, Zhang L, Guo J, Niu W. Functional genetic encoding of sulfotyrosine in mammalian cells. Nat Commun. 2020;11:4820.","journal-title":"Nat Commun"},{"key":"1641_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41589-020-0493-1","volume":"16","author":"JS Italia","year":"2020","unstructured":"Italia JS, Peeler JC, Hillenbrand CM, Latour C, Weerapana E, Chatterjee A. Genetically encoded protein sulfation in mammalian cells. Nat Chem Biol. 2020;16:379\u201382.","journal-title":"Nat Chem Biol"},{"key":"1641_CR48","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1038\/s41467-022-33111-4","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Jin S, Zhang M, Hu Y, Wu KL, Chung A, Wang S, Tian Z, Wang Y, Wolynes PG, Xiao H. Unleashing the potential of noncanonical amino acid biosynthesis to create cells with precision tyrosine sulfation. Nat Commun. 2022;13:5434.","journal-title":"Nat Commun"},{"key":"1641_CR49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ab.2010.08.005","volume":"407","author":"CH Jen","year":"2010","unstructured":"Jen CH, Leary JA. A competitive binding study of chemokine, sulfated receptor, and glycosaminoglycan interactions by nano-electrospray ionization mass spectrometry. Anal Biochem. 2010;407:134\u201340.","journal-title":"Anal Biochem"},{"key":"1641_CR50","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.biocel.2009.10.018","volume":"42","author":"SK Drake","year":"2010","unstructured":"Drake SK, Hortin GL. Improved detection of intact tyrosine sulfate-containing peptides by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry in linear negative ion mode. Int J Biochem Cell Biol. 2010;42:174\u20139.","journal-title":"Int J Biochem Cell Biol"},{"key":"1641_CR51","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/pmic.201100525","volume":"12","author":"S Cantel","year":"2012","unstructured":"Cantel S, Brunel L, Ohara K, Enjalbal C, Martinez J, Vasseur JJ, Smietana M. An innovative strategy for sulfopeptides analysis using MALDI-TOF MS reflectron positive ion mode. Proteomics. 2012;12:2247\u201357.","journal-title":"Proteomics"},{"key":"1641_CR52","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s13361-014-0910-3","volume":"25","author":"MR Robinson","year":"2014","unstructured":"Robinson MR, Moore KL, Brodbelt JS. Direct identification of tyrosine sulfation by using ultraviolet photodissociation mass spectrometry. J Am Soc Mass Spectrom. 2014;25:1461\u201371.","journal-title":"J Am Soc Mass Spectrom"},{"key":"1641_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1074\/jbc.M308689200","volume":"279","author":"P Onnerfjord","year":"2004","unstructured":"Onnerfjord P, Heathfield TF, Heinegard D. Identification of tyrosine sulfation in extracellular leucine-rich repeat proteins using mass spectrometry. J Biol Chem. 2004;279:26\u201333.","journal-title":"J Biol Chem"},{"key":"1641_CR54","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s13361-017-1854-1","volume":"29","author":"G Chen","year":"2018","unstructured":"Chen G, Zhang Y, Trinidad JC, Dann C 3rd. Distinguishing Sulfotyrosine Containing Peptides from their Phosphotyrosine Counterparts Using Mass Spectrometry. J Am Soc Mass Spectrom. 2018;29:455\u201362.","journal-title":"J Am Soc Mass Spectrom"},{"key":"1641_CR55","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cbpa.2020.05.007","volume":"58","author":"JWC Maxwell","year":"2020","unstructured":"Maxwell JWC, Payne RJ. Revealing the functional roles of tyrosine sulfation using synthetic sulfopeptides and sulfoproteins. Curr Opin Chem Biol. 2020;58:72\u201385.","journal-title":"Curr Opin Chem Biol"},{"key":"1641_CR56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev.biochem.70.1.437","volume":"70","author":"M Mann","year":"2001","unstructured":"Mann M, Hendrickson RC, Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem. 2001;70:437\u201373.","journal-title":"Annu Rev Biochem"},{"key":"1641_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ygcen.2007.12.006","volume":"156","author":"AD Westmuckett","year":"2008","unstructured":"Westmuckett AD, Hoffhines AJ, Borghei A, Moore KL. Early postnatal pulmonary failure and primary hypothyroidism in mice with combined TPST-1 and TPST-2 deficiency. Gen Comp Endocrinol. 2008;156:145\u201353.","journal-title":"Gen Comp Endocrinol"},{"key":"1641_CR58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","volume":"118","author":"I Tabas","year":"2016","unstructured":"Tabas I, Bornfeldt KE. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circ Res. 2016;118:653\u201367.","journal-title":"Circ Res"},{"key":"1641_CR59","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1046\/j.1523-1755.2001.00481.x","volume":"59","author":"I Fernandes","year":"2001","unstructured":"Fernandes I, Laouari D, Tutt P, Hampson G, Friedlander G, Silve C. Sulfate homeostasis, NaSi-1 cotransporter, and SAT-1 exchanger expression in chronic renal failure in rats. Kidney Int. 2001;59:210\u201321.","journal-title":"Kidney Int"},{"key":"1641_CR60","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/0026-0495(81)90053-6","volume":"30","author":"LS Phillips","year":"1981","unstructured":"Phillips LS, Kopple JD. Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function. Metabolism. 1981;30:1091\u20135.","journal-title":"Metabolism"},{"key":"1641_CR61","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1093\/ndt\/gfs382","volume":"27","author":"JZ Zhu","year":"2012","unstructured":"Zhu JZ, Zhang J, Yang K, Du R, Jing YJ, Lu L, Zhang RY. P-cresol, but not p-cresylsulphate, disrupts endothelial progenitor cell function in vitro. Nephrol Dial Transplant. 2012;27:4323\u201330.","journal-title":"Nephrol Dial Transplant"},{"key":"1641_CR62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","volume":"80","author":"AS Levey","year":"2011","unstructured":"Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17\u201328.","journal-title":"Kidney Int"},{"key":"1641_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4244\/EIJV5I1A9","volume":"5","author":"PW Serruys","year":"2009","unstructured":"Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009;5:50\u20136.","journal-title":"EuroIntervention"},{"key":"1641_CR64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3892\/wasj.2021.95","volume":"3","author":"D Dai","year":"2021","unstructured":"Dai D, Ruan Z, Han H, Zhu J, Zhang R. Relative quantitative analysis of human plasma O-sulfotyrosine using HPLC-MS\/MS in linear negative ion mode. World Acad Sci J. 2021;3:24.","journal-title":"World Acad Sci J"},{"key":"1641_CR65","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/1744-9987.12185","volume":"18","author":"J Ni","year":"2014","unstructured":"Ni J, Zhang W, Zhu Z, Zhu J, Du R, Jing Y, Lu L, Zhang R. In vivo kinetics of the uremic toxin p-cresyl sulfate in mice with variable renal function. Ther Apher Dial. 2014;18:637\u201342.","journal-title":"Ther Apher Dial"},{"key":"1641_CR66","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1160\/TH16-06-0475","volume":"117","author":"W Xiong","year":"2017","unstructured":"Xiong W, Wang X, Dai D, Zhang B, Lu L, Tao R. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE(-\/-) mice and inhibits monocyte\/macrophage recruitment. Thromb Haemost. 2017;117:401\u201314.","journal-title":"Thromb Haemost"},{"key":"1641_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001174","volume":"6","author":"Y Nishimura","year":"2010","unstructured":"Nishimura Y, Wakita T, Shimizu H. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 2010;6: e1001174.","journal-title":"PLoS Pathog"},{"key":"1641_CR68","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/eurheartj\/ehv649","volume":"37","author":"L Lu","year":"2016","unstructured":"Lu L, Zhang RY, Wang XQ, Liu ZH, Shen Y, Ding FH, Meng H, Wang LJ, Yan XX, Yang K, Wang HB, Pu LJ, Zhang Q, Chen QJ, De Caterina R, Shen WF. C1q\/TNF-related protein-1: an adipokine marking and promoting atherosclerosis. Eur Heart J. 2016;37:1762\u201371.","journal-title":"Eur Heart J"},{"key":"1641_CR69","doi-asserted-by":"publisher","first-page":"e99946","DOI":"10.1371\/journal.pone.0099946","volume":"9","author":"LF Zhang","year":"2014","unstructured":"Zhang LF, Qi J, Zuo G, Jia P, Shen X, Shao J, Kang H, Yang H, Deng L. Osteoblast-secreted factors promote proliferation and osteogenic differentiation of bone marrow stromal cells via VEGF\/heme-oxygenase-1 pathway. PLoS ONE. 2014;9:e99946.","journal-title":"PLoS ONE"}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-023-01641-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12915-023-01641-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-023-01641-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:01:55Z","timestamp":1688947315000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-023-01641-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1641"],"URL":"https:\/\/doi.org\/10.1186\/s12915-023-01641-y","relation":{},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"29 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol conformed to the principles outlined in the Declaration of Helsinki and was approved by the Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Written informed consent was obtained from all of the participants. The protocol in this study was approved by the institutional ethics committee of Ruijin Hospital (ID: 2020\u2013152), Shanghai, China. All animal experiments were in accordance with the experimental protocols approved by the Committee on Animal Resources of Shanghai Jiao Tong University. All procedures conformed to the NIH Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}